Iida, Mari <br/><br/>
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.  [electronic resource] 

 -  Molecular cancer therapeutics  09 2016 
 - 2175-86 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-16-0012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Carcinoma, Non-Small-Cell Lung<br/>Carcinoma, Squamous Cell<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cetuximab--pharmacology<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Head and Neck Neoplasms<br/>Humans<br/>Male<br/>Mice<br/>Protein Kinase Inhibitors--pharmacology<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Receptor, ErbB-3--antagonists & inhibitors<br/>Squamous Cell Carcinoma of Head and Neck<br/>Tumor Burden<br/>Xenograft Model Antitumor Assays